For her work leading innovative research into racial disparities in breast cancer care, Penn Medicine surgical resident and PC3I Innovation Fellow Sara Ginzberg, MD, recently received a Clinical Scholar Award from the prestigious San Antonio Breast Cancer Symposium.
“I was very pleased and humbled to receive this award on behalf of our amazing Penn Medicine team for our work on the use of preoperative breast MRI,” Ginzberg said. “I hope these study findings continue to stimulate discussion and, more importantly, advance equity in breast cancer care, both at Penn Medicine and beyond.”
In recent years oncologists have increasingly turned to MRI exams prior to breast cancer surgery as a way of more accurately assessing the state of the disease in the body. However, the study results from Ginzberg and her colleagues found that Black patients were less likely than their White counterparts to receive a breast MRI exam before surgery—a difference that could ultimately mean worse care outcomes for Black patients down the road. In 2022 only 10 researchers received Clinical Scholar Awards, which were created to support deserving early-career researchers who attend and present their findings at the San Antonio Breast Cancer Symposium, which is widely regarded as one of the most prominent annual events in the breast cancer research community.
For a novel investigation into a common and deadly form of liver cancer, PC3I Innovation Fellow Timothy Brown, MD, recently received an ASCO Conquer Cancer Merit Award.
Four Penn Center for Cancer Care Innovation (PC3I) Faculty will be presenting the latest advances in blood cancer research and treatment at the 64th American Society of Hematology (ASH) Annual Meeting and Exposition.
A $3.5 million grant from the National Cancer Institute (NCI) will help clinicians provide better care to women with cervical cancer in the nation of Botswana.